Follow
Raghu Sundaresan Nagalingam
Raghu Sundaresan Nagalingam
Verified email at houstonmethodist.org
Title
Cited by
Cited by
Year
SIRT3 blocks aging-associated tissue fibrosis in mice by deacetylating and activating glycogen synthase kinase 3β
NR Sundaresan, S Bindu, VB Pillai, S Samant, Y Pan, JY Huang, M Gupta, ...
Molecular and cellular biology 36 (5), 678-692, 2016
1782016
A novel cardiomyocyte-enriched microRNA, miR-378, targets insulin-like growth factor 1 receptor: implications in postnatal cardiac remodeling and cell survival
I Knezevic, A Patel, NR Sundaresan, MP Gupta, RJ Solaro, ...
Journal of Biological Chemistry 287 (16), 12913-12926, 2012
1682012
Role of scleraxis in mechanical stretch-mediated regulation of cardiac myofibroblast phenotype
PL Roche, RS Nagalingam, RA Bagchi, N Aroutiounova, BMJ Belisle, ...
American Journal of Physiology-Cell Physiology 311 (2), C297-C307, 2016
382016
Scleraxis regulates Twist1 and Snai1 expression in the epithelial-to-mesenchymal transition
DS Al-Hattab, HA Safi, RS Nagalingam, RA Bagchi, MT Stecy, MP Czubryt
American Journal of Physiology-Heart and Circulatory Physiology 315 (3 …, 2018
362018
Gaining myocytes or losing fibroblasts: challenges in cardiac fibroblast reprogramming for infarct repair
RS Nagalingam, HA Safi, MP Czubryt
Journal of molecular and cellular cardiology 93, 108-114, 2016
232016
Regulation of cardiac fibroblast MMP2 gene expression by scleraxis
RS Nagalingam, HA Safi, DS Al-Hattab, RA Bagchi, NM Landry, ...
Journal of molecular and cellular cardiology 120, 64-73, 2018
212018
CEBPβ regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth
MR Aghanoori, P Agarwal, E Gauvin, RS Nagalingam, R Bonomo, ...
Cellular and Molecular Life Sciences 79 (4), 193, 2022
162022
Scleraxis and fibrosis in the pressure-overloaded heart
RS Nagalingam, S Chattopadhyaya, DS Al-Hattab, DYC Cheung, ...
European Heart Journal 43 (45), 4739-4750, 2022
152022
What’s in a name? On fibroblast phenotype and nomenclature
RS Nagalingam, DS Al-Hattab, MP Czubryt
Canadian journal of physiology and pharmacology 97 (6), 493-497, 2019
122019
Elimination of endogenous high molecular weight FGF2 prevents pressure-overload-induced systolic dysfunction, linked to increased FGFR1 activity and NR1D1 expression
N Koleini, BE Nickel, RS Nagalingam, NM Landry, RR Fandrich, ...
Cell and Tissue Research 385 (3), 753-768, 2021
82021
Regulation of cardiac fibroblast GLS1 expression by scleraxis
S Chattopadhyaya, RS Nagalingam, DA Ledingham, TL Moffatt, ...
Cells 11 (9), 1471, 2022
72022
Scleraxis as a prognostic marker of myocardial fibrosis in hypertrophic cardiomyopathy (SPARC) study
A Zhu, H Bews, D Cheung, RS Nagalingam, I Mittal, V Goyal, CY Asselin, ...
Canadian Journal of Physiology and Pharmacology 98 (7), 459-465, 2020
42020
Scleraxis: a force-responsive cell phenotype regulator
HA Safi, RS Nagalingam, MP Czubryt
Current Opinion in Physiology 1, 104-110, 2018
32018
A novel cardiomyocyte enriched microRNA, miR-378, targets IGF1R: implications in post natal cardiac remodeling and cell survival
I Knezevic, A Patel, NR Sundaresan, MP Gupta, RJ Solaro, ...
University of Illinois at Chicago, 2012
32012
Targeted activation of human ether-à-go-go-related gene channels rescues electrical instability induced by the R56Q+/− long QT syndrome variant
R Venkateshappa, DV Hunter, P Muralidharan, RS Nagalingam, G Huen, ...
Cardiovascular Research 119 (15), 2522-2535, 2023
22023
Changes in gene expression caused by genetic elimination of high molecular weight FGF2 are associated with prevention of stress‐induced cardiac systolic dysfunction
E Kardami, N Koleini, B Nickel, R Nagalingam, NM Landry, RR Fandrich, ...
The FASEB Journal 34 (S1), 1-1, 2020
22020
Cardiomyocyte enriched microRNA, mir-378, regulates hypertrophy agonists stimulated growth of cardiac myocytes
RS Nagalingam, RJ Solaro, MP Gupta, NR Sundaresan, M Gupta
Circulation 126 (suppl_21), A19199-A19199, 2012
22012
Mechanisms of Pathogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant R278C+/− During Development
S Shafaattalab, AY Li, F Jayousi, Y Maaref, S Dababneh, H Hamledari, ...
bioRxiv, 2023
12023
High Molecular Weight FGF2 Contributes to Pressure Overload Induced Systolic Dysfunction by a Mechanism Associated With Modulation of the NR1D1 Orphan Nuclear Receptor Expression
N Koleini, BE Nickel, RS Nagalingam, NM Landry, RR Fandrich, IM Dixon, ...
Circulation Research 125 (Suppl_1), A838-A838, 2019
12019
Deficiency of Microrna-378 Contributes to the Development of Cardiac Fibrosis Involving a Tgfβ1-dependent Paracrine Mechanism
RS Nagalingam, M Noor, MP Gupta, RJ Solaro, M Gupta
Circulation 130 (suppl_2), A13392-A13392, 2014
12014
The system can't perform the operation now. Try again later.
Articles 1–20